Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Doyeon Hwang

Showing results (121-130 of 181) with videos related to

Pageof 19
Sort By:
JACC. Asia|March 6, 2023
Prasugrel-Based De-Escalation in Patients With Acute Coronary Syndrome According to Renal FunctionJun Pil Yun, Jeehoon Kang, Kyung Woo Park, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|November 23, 2018
Prognostic Impact of β-Blocker Dose After Acute Myocardial InfarctionDoyeon Hwang, Joo Myung Lee, Hyun Kuk Kim, et al.
Circulation|March 5, 2023
Comparison of 3- to 6-Month Versus 12-Month Dual Antiplatelet Therapy After Coronary Intervention Using the Contemporary Drug-Eluting Stents With Ultrathin Struts: The HOST-IDEA Randomized Clinical TrialJung-Kyu Han, Doyeon Hwang, Seokhun Yang, et al.
JAMA Cardiology|November 27, 2024
Long-Term Aspirin vs Clopidogrel After Coronary Stenting by Bleeding Risk and Procedural ComplexityJeehoon Kang, Jaewook Chung, Kyung Woo Park, et al.
Eclinicalmedicine|January 9, 2026
Abbreviated dual antiplatelet therapy after percutaneous coronary intervention with ultrathin-strut drug-eluting stents in South Korea: 3-year outcomes of the multicentre, randomised HOST-IDEA trialJung-Kyu Han, Doyeon Hwang, Seokhun Yang, et al.
International Journal of Cardiology|September 10, 2020
Clinical relevance and prognostic implications of contrast quantitative flow ratio in patients with coronary artery diseaseKi Hong Choi, Seung Hun Lee, Joo Myung Lee, et al.
JAMA Cardiology|March 9, 2022
Prasugrel Dose De-escalation Therapy After Complex Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome: A Post Hoc Analysis From the HOST-REDUCE-POLYTECH-ACS TrialDoyeon Hwang, Young-Hyo Lim, Kyung Woo Park, et al.
Journal of the American Heart Association|February 20, 2026
Biodegradable Polymer Versus Polymer-Free Ultrathin Sirolimus-Eluting Stents in Complex Percutaneous Coronary Intervention: Post Hoc Analysis of the Stent Arm Registry From the HOST-IDEA Randomized TrialSang-Hyeon Park, Jung-Kyu Han, Seokhun Yang, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|October 14, 2024
Renal Function-Stratified Comparison of Short- and Long-Term Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention With Third-Generation Drug-Eluting Stents - Post Hoc Analysis From the HOST-IDEA Randomized Clinical TrialJung-Kyu Han, Seung Do Lee, Doyeon Hwang, et al.
Circulation. Cardiovascular Interventions|May 24, 2024
Biodegradable Polymer Versus Polymer-Free Ultrathin Sirolimus-Eluting Stents: Analysis of the Stent Arm Registry From the HOST-IDEA Randomized TrialJung-Kyu Han, Seokhun Yang, Doyeon Hwang, et al.
Pageof 19

Showing results (121-130 of 181) with videos related to

Sort By:
Pageof 19
JACC. Asia|March 6, 2023
Prasugrel-Based De-Escalation in Patients With Acute Coronary Syndrome According to Renal FunctionJun Pil Yun, Jeehoon Kang, Kyung Woo Park, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|November 23, 2018
Prognostic Impact of β-Blocker Dose After Acute Myocardial InfarctionDoyeon Hwang, Joo Myung Lee, Hyun Kuk Kim, et al.
Circulation|March 5, 2023
Comparison of 3- to 6-Month Versus 12-Month Dual Antiplatelet Therapy After Coronary Intervention Using the Contemporary Drug-Eluting Stents With Ultrathin Struts: The HOST-IDEA Randomized Clinical TrialJung-Kyu Han, Doyeon Hwang, Seokhun Yang, et al.
JAMA Cardiology|November 27, 2024
Long-Term Aspirin vs Clopidogrel After Coronary Stenting by Bleeding Risk and Procedural ComplexityJeehoon Kang, Jaewook Chung, Kyung Woo Park, et al.
Eclinicalmedicine|January 9, 2026
Abbreviated dual antiplatelet therapy after percutaneous coronary intervention with ultrathin-strut drug-eluting stents in South Korea: 3-year outcomes of the multicentre, randomised HOST-IDEA trialJung-Kyu Han, Doyeon Hwang, Seokhun Yang, et al.
International Journal of Cardiology|September 10, 2020
Clinical relevance and prognostic implications of contrast quantitative flow ratio in patients with coronary artery diseaseKi Hong Choi, Seung Hun Lee, Joo Myung Lee, et al.
JAMA Cardiology|March 9, 2022
Prasugrel Dose De-escalation Therapy After Complex Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome: A Post Hoc Analysis From the HOST-REDUCE-POLYTECH-ACS TrialDoyeon Hwang, Young-Hyo Lim, Kyung Woo Park, et al.
Journal of the American Heart Association|February 20, 2026
Biodegradable Polymer Versus Polymer-Free Ultrathin Sirolimus-Eluting Stents in Complex Percutaneous Coronary Intervention: Post Hoc Analysis of the Stent Arm Registry From the HOST-IDEA Randomized TrialSang-Hyeon Park, Jung-Kyu Han, Seokhun Yang, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|October 14, 2024
Renal Function-Stratified Comparison of Short- and Long-Term Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention With Third-Generation Drug-Eluting Stents - Post Hoc Analysis From the HOST-IDEA Randomized Clinical TrialJung-Kyu Han, Seung Do Lee, Doyeon Hwang, et al.
Circulation. Cardiovascular Interventions|May 24, 2024
Biodegradable Polymer Versus Polymer-Free Ultrathin Sirolimus-Eluting Stents: Analysis of the Stent Arm Registry From the HOST-IDEA Randomized TrialJung-Kyu Han, Seokhun Yang, Doyeon Hwang, et al.
Pageof 19